Skip to content

Early Occupational Therapy Intervention in the Hospital Discharge After Stroke

Early Occupational Therapy Intervention in the Hospital Discharge After Stroke: Study Protocol for a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04835363
Enrollment
117
Registered
2021-04-08
Start date
2021-05-01
Completion date
2022-11-30
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

patient discharge, occupational therapy, rehabilitation, caregivers

Brief summary

The general objective of this study is to determine if an early occupational therapy (OT) intervention together with the usual care at hospital discharge after suffering a stroke has a positive effect on the quality of life and functional independence of the patient, compared with the control group that will have the usual care and rehabilitation. We designed a four-week OT intervention program in patients who have suffered a stroke with the aim of improving the functional result and facilitating the return home by providing knowledge to the caregiver about specific care and neurorehabilitation.

Detailed description

Background: Stroke is the leading cause of acquired disability in adults, being a cerebrovascular disease of great impact in health and social terms, due not only to its prevalence and incidence, but to the great repercussion in terms of dependence and its consequent impact on the life of the patient and family. General and specific objectives: The general objective of this study is to determine if an early occupational therapy (OT) intervention together with the usual care at hospital discharge after suffering a stroke has a positive effect on the quality of life of the patient, compared with the control group that will have the usual care and rehabilitation. We designed a four-week OT intervention program with the support of the main caregiver in patients who have suffered a stroke with the aim of improving the functional result and facilitating the return home by providing knowledge about specific care and neurorehabilitation. Primary outcome: quality of life and functional independence. Secondary outcomes: improvement in sensory-motor skills, perceptual-cognitive skills, communication skills, levels of anxiety and depression of the patient, as well as caregivers' burden and coping strategies. The final results are evaluated three months after discharge. Study Design: This is a prospective, randomized, controlled clinical trial. The sample size is made up of 60 patients who will be divided into two groups: the control group, with 30 users, and the experimental group, with another 30 users. The sample will be made up of patients who have suffered a stroke and have been discharged from the neurology service of a second-level hospital in West Malaga (Spain), being referred to the rehabilitation service by joint decision of the neurology and rehabilitation department. Patients assigned to the experimental group and their caregivers are included in an early occupational therapy intervention program and compared with a control group that receives usual care and rehabilitation.

Interventions

OTHEREarly Occupational Therapy intervention

four-week OT intervention program for patients who have suffered a stroke with the aim of improving the functional result and facilitating the return home by providing knowledge about specific care and neurorehabilitation.

Sponsors

University of Malaga
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of stroke with single or multiple vascular lesions that have occurred in the same time period, demonstrated by neuroimaging tests (CT or MRI). * 18 years of age or older. * Patient must live a maximum of 30 minutes away from the hospital center. * Must present \> 2 or \<26 points on the National Institute of Health scale (NIHSS) and 30-100 points on the Barthel Index (BI) on the second day of the stroke (with BI 100, the patient can be included if the Montreal Cognitive Assessment is \<26). * Patient must present some motor deficit that makes it difficult to carry out his ADL. * Inclusion in the study occurs prior to hospital discharge.

Exclusion criteria

* NIHSS\> 26 and BI \<30. * Life expectancy \<1 year. * Previous stroke, dementia or other types of illnesses associated with dementia and other neurological, psychiatric or medical illnesses (for example, severe epilepsy, head trauma, schizophrenia, COPD, severe or unstable heart disease, sleep apnea) that could alter cognitive function. * Moderate-severe aphasia. * Does not understand Spanish or English.

Design outcomes

Primary

MeasureTime frameDescription
Patient Quality of LifeBefore intervention (baseline) and after intervention (3 months)Assessed with Stroke and aphasia quality of life scale-39 (SAQOL-39). Unit of measure will be the result of this assessment. Final score goes from 0 to 195 (higher score, better outcome).

Secondary

MeasureTime frameDescription
Anxiety of the PatientBefore intervention (baseline) and after intervention (3 months)Assessed with Hamilton anxiety scale. This scale assesses the severity of anxiety globally in patients who meet criteria for anxiety or depression. Unit of measure will be the result of this assessment. Final score goes from 0 to 56 (lower score, better outcome).
Patient's Sensory-motor SkillsBefore intervention (baseline) and after intervention (3 months)Assessed with Fugl Meyer Assessment (FMA). Unit of measure will be the result of this assessment. Total score is 0 to 126 (the higher score, the better upper limb sensory-motor skills).
Patient Perceptual-cognitive SkillsBefore intervention (baseline) and after intervention (3 months)Assessed with Montreal Cognitive Assessment (MoCA). MoCA has been proposed as a screening tool that promises good sensitivity to deficits that result from stroke and vascular cognitive impairment. Unit of measure will be the result of this assessment.The final score goes from 0 to 30 (higher score, better outcome).
Patient Communication SkillsBefore intervention (baseline) and after intervention (3 months)Assessed with Communicative Activity Log (CAL). Scale that allows obtaining information on communication skills in activities of daily life referring to comprehensive and expressive aspects of language. Unit of measure will be the result of this assessment. Final score goes from 0 to 190 (higher score, better outcome).
Depression of the PatientBefore intervention (baseline) and after intervention (3 months)Assessed with Beck Depression Inventory (BDI-2). It is one of the most commonly used instruments to measure the severity of depression. Unit of measure will be the result of this assessment. Final score goes from 0 to 63 (lower score, better outcome).
Patient Functional Independence Assessed With Stroke Impact Scale-16Before intervention (baseline) and after intervention (3 months)Unit of measure will be the result of this assessment. The score goes from 16 to 80, 80 meaning independence (higher score, better outcome). The usefulness of this scale is similar to that of the Barthel Index, although it is more sensitive than the latter to discriminate between patients with mild disabilities.
Patient Disability Assessed With Modified Rankin Scale (mRs)Before intervention (baseline) and after intervention (3 months)The mRS is used to describe disability in general. Unit of measure will be the result of this assessment. The score goes from 0 to 6, 0 meaning no symptoms and 6 meaning death (higher score, worse outcome).
Patient MobilityBefore intervention (baseline) and after intervention (3 months)Assessed with Time up and go (TUG). The TUG assesses basic mobility, timing the time required for a person to get up from a standardized chair, walk a distance of three meters, turn, return to the chair, and sit down again. Unit of measure will be the result of this assessment, which is the time in seconds. Shorter time means better performance.
Patient Functional BalanceBefore intervention (baseline) and after intervention (3 months)Assessed with Berg Balance Scale (BBS) which evaluates assesses functional balance. Unit of measure will be the result of this assessment. Final score goes from 0 to 56 (higher score, better outcome).
Patient Functional Independence Assessed With Barthel IndexBefore intervention (baseline) and after intervention (3 months)The main unit of measure is the result of Barthel Index (from 0 to 100), 0 meaning disability and 100 meaning independence, therefore, higher score, better outcome. The main goal of this research is to assess independence of the patient and support needs in activities of daily living. The Barthel index measures the extent to which someone can function independently during basic activities of daily living.

Other

MeasureTime frameDescription
Caregiver Burden.Before intervention (baseline) and after intervention (3 months)Caregiver burden was evaluated with Caregiver Burden Scale (CBS). The Caregiver Burden Scale (CBS) is a 22-item scale that assesses the burden subjectively experienced by caregivers.The total score range is 0 to 88, where the higher the score, the more severe the burden: 0-21 no or mild burden, 21-40 mild to moderate burden, 41-60 moderate to severe burden, and ≥61 severe burden.
Caregivers Coping Strategies.Before intervention (baseline) and after intervention (3 months)The caregivers coping strategies were evaluated with the Coping Strategies Inventory (CSI), that was adapted to 40 items. The scale measures individual coping strategies that are broadly classified into two basic approaches to managing stressful situations: coping activities that involve the individual in the stressful situation (engagement strategies) and coping activities that disengage the individual (disengagement strategies). Total subscales score range are: disengagement strategies 0 to 60 and engagement strategies 0 to 60. The higher the score, the more strategies of that type they have.

Countries

Spain

Participant flow

Pre-assignment details

Out of all the patients that were asked for enrollment, only 55 had a relative or friend as a caregiver and agreed to cooperate with the research.

Participants by arm

ArmCount
Control Group - Patients
Usual care provided by hospital/community staff.
31
EOTIPS (OT Intervention) - Patients
Patients and their caregivers assigned to the experimental group are included in an early occupational therapy intervention program. Early Occupational Therapy intervention: four-week OT intervention program with the support of the main caregiver in patients who have suffered a stroke with the aim of improving quality of life and facilitating the return home by providing knowledge to the caregiver about specific care and neurorehabilitation.
31
Control Group - Caregivers
Caregivers of patients who received usual care by ward and rehabilitation staff.
27
EOTIPS (OT Intervention) - Caregivers
Caregivers of patients assigned to the experimental group who are included in an early occupational therapy intervention program. Early Occupational Therapy intervention (EOTIPS): four-week OT intervention program with the support of the main caregiver in patients who have suffered a stroke with the aim of improving patient quality of life and facilitating the return home by providing knowledge to the caregiver about specific care and neurorehabilitation.
28
Total117

Baseline characteristics

CharacteristicControl Group - PatientsEOTIPS (OT Intervention) - PatientsControl Group - CaregiversEOTIPS (OT Intervention) - CaregiversTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
15 Participants13 Participants3 Participants5 Participants36 Participants
Age, Categorical
Between 18 and 65 years
16 Participants18 Participants24 Participants23 Participants81 Participants
Age, Continuous66.6 years
STANDARD_DEVIATION 10.6
68.5 years
STANDARD_DEVIATION 10.7
60 years
STANDARD_DEVIATION 22.3
61.2 years
STANDARD_DEVIATION 19.8
67.5 years
STANDARD_DEVIATION 10.6
Education
High school
5 Participants3 Participants8 Participants
Education
No studies
1 Participants1 Participants2 Participants
Education
Primary school
15 Participants9 Participants24 Participants
Education
Reads/writes
8 Participants12 Participants20 Participants
Education
University
2 Participants6 Participants8 Participants
Employment status
Househusband/housewife
1 Participants4 Participants5 Participants
Employment status
Other activities
0 Participants1 Participants1 Participants
Employment status
Retired
20 Participants18 Participants38 Participants
Employment status
Temporary disability
8 Participants7 Participants15 Participants
Employment status
Unemployed
2 Participants1 Participants3 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
28 Participants25 Participants25 Participants23 Participants101 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants6 Participants2 Participants5 Participants16 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Marital status
Divorced
2 Participants2 Participants4 Participants
Marital status
Married/living with partner
21 Participants20 Participants41 Participants
Marital status
Single
2 Participants3 Participants5 Participants
Marital status
Widowed
6 Participants6 Participants12 Participants
Native language: spanish29 Participants29 Participants26 Participants26 Participants110 Participants
Region of Enrollment
Spain
31 participants31 participants27 participants28 participants117 participants
Sex: Female, Male
Female
15 Participants12 Participants15 Participants20 Participants62 Participants
Sex: Female, Male
Male
16 Participants19 Participants12 Participants8 Participants55 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
1 / 311 / 310 / 270 / 28
other
Total, other adverse events
0 / 310 / 310 / 270 / 28
serious
Total, serious adverse events
0 / 310 / 310 / 270 / 28

Outcome results

Primary

Patient Quality of Life

Assessed with Stroke and aphasia quality of life scale-39 (SAQOL-39). Unit of measure will be the result of this assessment. Final score goes from 0 to 195 (higher score, better outcome).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: Patients that enrolled EOTIPS program were assessed with SAQOL-39 in order to define wether their quality of life has improved, comparing to a control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient Quality of LifeAfter intervention (3 months)3.41 score on a scaleStandard Deviation 0.69
Control GroupPatient Quality of LifeBefore intervention (baseline)2.51 score on a scaleStandard Deviation 0.75
OT Intervention.Patient Quality of LifeAfter intervention (3 months)3.91 score on a scaleStandard Deviation 0.7
OT Intervention.Patient Quality of LifeBefore intervention (baseline)2.67 score on a scaleStandard Deviation 0.72
p-value: 0.029ANOVA
Secondary

Anxiety of the Patient

Assessed with Hamilton anxiety scale. This scale assesses the severity of anxiety globally in patients who meet criteria for anxiety or depression. Unit of measure will be the result of this assessment. Final score goes from 0 to 56 (lower score, better outcome).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: Anxiety of the patient was assessed with Hamilton anxiety scale to define if it improved more in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupAnxiety of the PatientAfter intervention (3 months).11.3 score on a scaleStandard Deviation 9.4
Control GroupAnxiety of the PatientBefore intervention (baseline).11.50 score on a scaleStandard Deviation 10.88
OT Intervention.Anxiety of the PatientAfter intervention (3 months).5.5 score on a scaleStandard Deviation 7.94
OT Intervention.Anxiety of the PatientBefore intervention (baseline).8.47 score on a scaleStandard Deviation 10.96
p-value: 0.055ANOVA
Secondary

Depression of the Patient

Assessed with Beck Depression Inventory (BDI-2). It is one of the most commonly used instruments to measure the severity of depression. Unit of measure will be the result of this assessment. Final score goes from 0 to 63 (lower score, better outcome).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: Depression was assessed with Beck Depression Inventory (BDI-2) to define if the level of depression was lower in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupDepression of the PatientAfter intervention (3 months).15.3 score on a scaleStandard Deviation 10.48
Control GroupDepression of the PatientBefore intervention (baseline).13.60 score on a scaleStandard Deviation 9.76
OT Intervention.Depression of the PatientAfter intervention (3 months).8.4 score on a scaleStandard Deviation 8.88
OT Intervention.Depression of the PatientBefore intervention (baseline).11.23 score on a scaleStandard Deviation 9.11
p-value: 0.011ANOVA
Secondary

Patient Communication Skills

Assessed with Communicative Activity Log (CAL). Scale that allows obtaining information on communication skills in activities of daily life referring to comprehensive and expressive aspects of language. Unit of measure will be the result of this assessment. Final score goes from 0 to 190 (higher score, better outcome).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: Communication was assessed with Communicative Activity Log (CAL) to define if the communication skills were better in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient Communication SkillsAfter intervention (3 months).116 Score on a scaleStandard Deviation 31.1
Control GroupPatient Communication SkillsBefore intervention (baseline).109.00 Score on a scaleStandard Deviation 37
OT Intervention.Patient Communication SkillsAfter intervention (3 months).137 Score on a scaleStandard Deviation 24.2
OT Intervention.Patient Communication SkillsBefore intervention (baseline).122.00 Score on a scaleStandard Deviation 27.3
p-value: 0.078ANOVA
Secondary

Patient Disability Assessed With Modified Rankin Scale (mRs)

The mRS is used to describe disability in general. Unit of measure will be the result of this assessment. The score goes from 0 to 6, 0 meaning no symptoms and 6 meaning death (higher score, worse outcome).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: The patient general disability was assessed with modified Rankin scale to define if it improved more in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient Disability Assessed With Modified Rankin Scale (mRs)After intervention (3 months).2.5 Score on a scaleStandard Deviation 1.04
Control GroupPatient Disability Assessed With Modified Rankin Scale (mRs)Before intervention (baseline).3.60 Score on a scaleStandard Deviation 0.77
OT Intervention.Patient Disability Assessed With Modified Rankin Scale (mRs)After intervention (3 months).1.83 Score on a scaleStandard Deviation 1.05
OT Intervention.Patient Disability Assessed With Modified Rankin Scale (mRs)Before intervention (baseline).3.63 Score on a scaleStandard Deviation 0.8
p-value: 0.004ANOVA
Secondary

Patient Functional Balance

Assessed with Berg Balance Scale (BBS) which evaluates assesses functional balance. Unit of measure will be the result of this assessment. Final score goes from 0 to 56 (higher score, better outcome).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: Functional balance was assessed with Berg Balance Scale (BBS) to define if it improved more in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient Functional BalanceAfter intervention (3 months).45.3 score on a scaleStandard Deviation 11.7
Control GroupPatient Functional BalanceBefore intervention (baseline).22.70 score on a scaleStandard Deviation 17.9
OT Intervention.Patient Functional BalanceAfter intervention (3 months).47 score on a scaleStandard Deviation 11.1
OT Intervention.Patient Functional BalanceBefore intervention (baseline).27.60 score on a scaleStandard Deviation 14.6
p-value: 0.358ANOVA
Secondary

Patient Functional Independence Assessed With Barthel Index

The main unit of measure is the result of Barthel Index (from 0 to 100), 0 meaning disability and 100 meaning independence, therefore, higher score, better outcome. The main goal of this research is to assess independence of the patient and support needs in activities of daily living. The Barthel index measures the extent to which someone can function independently during basic activities of daily living.

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: The functional independence was assessed with Barthel Index to define if it improved more in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient Functional Independence Assessed With Barthel IndexAfter intervention (3 months).85 score on a scaleStandard Error 16.7
Control GroupPatient Functional Independence Assessed With Barthel IndexBefore intervention (baseline).52.5 score on a scaleStandard Error 21
OT Intervention.Patient Functional Independence Assessed With Barthel IndexAfter intervention (3 months).90 score on a scaleStandard Error 14.9
OT Intervention.Patient Functional Independence Assessed With Barthel IndexBefore intervention (baseline).54.7 score on a scaleStandard Error 20.5
p-value: 0.496ANOVA
Secondary

Patient Functional Independence Assessed With Stroke Impact Scale-16

Unit of measure will be the result of this assessment. The score goes from 16 to 80, 80 meaning independence (higher score, better outcome). The usefulness of this scale is similar to that of the Barthel Index, although it is more sensitive than the latter to discriminate between patients with mild disabilities.

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: The functional independence was assessed with SIS-16 to define if it improved more in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient Functional Independence Assessed With Stroke Impact Scale-16After intervention (3 months).61.9 score on a scaleStandard Deviation 12.6
Control GroupPatient Functional Independence Assessed With Stroke Impact Scale-16Before intervention (baseline).36.60 score on a scaleStandard Deviation 14
OT Intervention.Patient Functional Independence Assessed With Stroke Impact Scale-16After intervention (3 months).66.3 score on a scaleStandard Deviation 10.7
OT Intervention.Patient Functional Independence Assessed With Stroke Impact Scale-16Before intervention (baseline).37.70 score on a scaleStandard Deviation 11
p-value: 0.241ANOVA
Secondary

Patient Mobility

Assessed with Time up and go (TUG). The TUG assesses basic mobility, timing the time required for a person to get up from a standardized chair, walk a distance of three meters, turn, return to the chair, and sit down again. Unit of measure will be the result of this assessment, which is the time in seconds. Shorter time means better performance.

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: Basic mobility was assessed with Timed Up and Go (TUG)) to define if it improved more in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient MobilityAfter intervention (3 months).12.4 secondsStandard Deviation 4.83
Control GroupPatient MobilityBefore intervention (baseline).28.40 secondsStandard Deviation 17.68
OT Intervention.Patient MobilityAfter intervention (3 months).14.3 secondsStandard Deviation 12.8
OT Intervention.Patient MobilityBefore intervention (baseline).29.00 secondsStandard Deviation 12.9
p-value: 0.797ANOVA
Secondary

Patient Perceptual-cognitive Skills

Assessed with Montreal Cognitive Assessment (MoCA). MoCA has been proposed as a screening tool that promises good sensitivity to deficits that result from stroke and vascular cognitive impairment. Unit of measure will be the result of this assessment.The final score goes from 0 to 30 (higher score, better outcome).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: Cognitive impairment was assessed with Montreal Cognitive Assessment (MoCA) to define if cognition has improved in the EOTIPS group compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient Perceptual-cognitive SkillsAfter intervention (3 months).20.1 Score on a scaleStandard Deviation 7.06
Control GroupPatient Perceptual-cognitive SkillsBefore intervention (baseline).16.6 Score on a scaleStandard Deviation 7.33
OT Intervention.Patient Perceptual-cognitive SkillsAfter intervention (3 months).24.8 Score on a scaleStandard Deviation 6.58
OT Intervention.Patient Perceptual-cognitive SkillsBefore intervention (baseline).18.6 Score on a scaleStandard Deviation 7.16
p-value: 0.012ANOVA
Secondary

Patient's Sensory-motor Skills

Assessed with Fugl Meyer Assessment (FMA). Unit of measure will be the result of this assessment. Total score is 0 to 126 (the higher score, the better upper limb sensory-motor skills).

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: All participants were assessed with Fugl-Meyer sensory motor assessment (FMA) in order to define wether EOTIPS program induced an improvement in the motor upper limb functions compared to the control group.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupPatient's Sensory-motor SkillsAfter intervention (3 months)111.10 Score on a scaleStandard Deviation 17.6
Control GroupPatient's Sensory-motor SkillsBefore intervention (baseline).99.80 Score on a scaleStandard Deviation 22.6
OT Intervention.Patient's Sensory-motor SkillsAfter intervention (3 months)117 Score on a scaleStandard Deviation 12.6
OT Intervention.Patient's Sensory-motor SkillsBefore intervention (baseline).102.00 Score on a scaleStandard Deviation 18.9
p-value: 0.148ANOVA
Other Pre-specified

Caregiver Burden.

Caregiver burden was evaluated with Caregiver Burden Scale (CBS). The Caregiver Burden Scale (CBS) is a 22-item scale that assesses the burden subjectively experienced by caregivers.The total score range is 0 to 88, where the higher the score, the more severe the burden: 0-21 no or mild burden, 21-40 mild to moderate burden, 41-60 moderate to severe burden, and ≥61 severe burden.

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: The caregivers that wanted to participate in the study were evaluated.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupCaregiver Burden.After intervention (3 months).3.91 Score on a scaleStandard Deviation 0.7
Control GroupCaregiver Burden.Before intervention (baseline).12.8 Score on a scaleStandard Deviation 12.6
OT Intervention.Caregiver Burden.Before intervention (baseline).14.5 Score on a scaleStandard Deviation 6.91
OT Intervention.Caregiver Burden.After intervention (3 months).3.41 Score on a scaleStandard Deviation 0.69
p-value: 0.019ANOVA
Other Pre-specified

Caregivers Coping Strategies.

The caregivers coping strategies were evaluated with the Coping Strategies Inventory (CSI), that was adapted to 40 items. The scale measures individual coping strategies that are broadly classified into two basic approaches to managing stressful situations: coping activities that involve the individual in the stressful situation (engagement strategies) and coping activities that disengage the individual (disengagement strategies). Total subscales score range are: disengagement strategies 0 to 60 and engagement strategies 0 to 60. The higher the score, the more strategies of that type they have.

Time frame: Before intervention (baseline) and after intervention (3 months)

Population: The caregivers that were involved in the recovery of the patients were included in the study and evaluated.

ArmMeasureGroupValue (MEAN)Dispersion
Control GroupCaregivers Coping Strategies.Engagement strategies - BEFORE38.2 Score on a scaleStandard Deviation 12.6
Control GroupCaregivers Coping Strategies.Disengagement strategies - BEFORE33.9 Score on a scaleStandard Deviation 6.8
Control GroupCaregivers Coping Strategies.Engagement strategies - AFTER40.8 Score on a scaleStandard Deviation 13.6
Control GroupCaregivers Coping Strategies.Disengagement strategies - AFTER37.4 Score on a scaleStandard Deviation 7.95
OT Intervention.Caregivers Coping Strategies.Disengagement strategies - AFTER38.0 Score on a scaleStandard Deviation 7.6
OT Intervention.Caregivers Coping Strategies.Engagement strategies - BEFORE42.5 Score on a scaleStandard Deviation 10.2
OT Intervention.Caregivers Coping Strategies.Engagement strategies - AFTER49.0 Score on a scaleStandard Deviation 10.5
OT Intervention.Caregivers Coping Strategies.Disengagement strategies - BEFORE36.4 Score on a scaleStandard Deviation 8.18
Comparison: ENGAGEMENT STRATEGIESp-value: 0.141ANOVA
Comparison: DISENGAGEMENT STRATEGIESp-value: 0.496ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026